Glassman Wealth Services United Therapeutics Corp Transaction History

Glassman Wealth Services

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$214.88 - $256.94 $429 - $513	2 Added 1.57%	129 $28,000
Q2 2023 Aug 08, 2023	BUY	$205.19 - $232.99 $205 - $232	1 Added 0.79%	127 $28,000
Q1 2023 May 04, 2023	BUY	$212.99 - $276.17 $212 - $276	1 Added 0.8%	126 $28,000
Q4 2022 Feb 06, 2023	SELL	$205.95 - $280.43 $617 - $841	-3 Reduced 2.34%	125 $34,000
Q1 2022 Apr 14, 2022	BUY	$166.16 - $213.96 $996 - $1,283	6 Added 4.92%	128 $23,000
Q3 2021 Nov 10, 2021	BUY	$179.86 - $214.88 $359 - $429	2 Added 1.67%	122 $23,000
Q1 2021 May 05, 2021	BUY	$153.94 - $174.85 $923 - $1,049	6 Added 5.26%	120 $20,000
Q4 2020 Feb 04, 2021	BUY	$101.87 - $151.79 $3,667 - $5,464	36 Added 46.15%	114 $17,000
Q3 2020 Nov 09, 2020	SELL	$99.9 - $121.13 $399 - $484	-4 Reduced 4.88%	78 $8,000
Q2 2020 Aug 06, 2020	BUY	$92.74 - $125.82 $5,842 - $7,926	63 Added 331.58%	82 $10,000
Q3 2019 Nov 01, 2019	BUY	$74.85 - $85.99 $1,347 - $1,547	18 Added 1800.0%	19 $2,000
Q2 2019 Aug 08, 2019	BUY	$76.06 - $120.81 $76 - $120	1 New	1 $0

681

42.2M

194K

298K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.